U.S. market Closed. Opens in 1 day 11 hours 18 minutes

MTACW | MedTech Acquisition Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
Revenue18.51M12.40M8.40M5.43M
Cost of Revenue2.60M2.26M1.19M2.20M
Gross Profit15.91M10.14M7.21M3.24M
Operating Expenses70.06M46.58M31.24M29.02M
Selling, General & Admin40.55M25.22M17.02M13.06M
Research & Development29.51M21.36M14.22M15.82M
Other Operating Expenses-379.00K-8.73M746.00KN/A
Operating Income-54.15M-36.44M-24.03M-25.65M
Other Expenses / Income-5.29M-10.92M-3.05M-6.18M
Before Tax Income-59.03M-47.18M-28.84M-31.83M
Income Tax Expenses9.00K9.00K3.00K4.00K
Net Income-59.04M-47.19M-28.84M-31.83M
Interest Expenses16.00K1.00K1.76MN/A
Basic Shares Outstanding9.40M29.61M31.25M30.56M
Diluted Shares Outstanding9.40M29.61M31.25M30.56M
EBITDA-53.40M-44.59M-22.82M-25.32M
EBITDA Margin-288.46%-359.68%-271.66%-466.05%
EBIT-59.01M-47.18M-27.08M-31.83M
EBIT Margin-318.80%-380.52%-322.35%-585.68%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙